MedTrace Logo

Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

NCT05442177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-07-01

No results posted yet for this study

Summary

We conducted an observational study to investigate the effectiveness and safety of Integrated Chinese Medicine With Western Medicine for bone marrow suppression induced by chemotherapy in patients with cancer. The TCM constitution and pulse diagnosis was also observed in the study.

Conditions

  • Myelosuppression

Interventions

PROCEDURE

Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment

Sponsors & Collaborators

  • Taichung Tzu Chi Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442177 on ClinicalTrials.gov